CN104147194A - 一种治疗慢性鼻窦炎的中药组合物 - Google Patents
一种治疗慢性鼻窦炎的中药组合物 Download PDFInfo
- Publication number
- CN104147194A CN104147194A CN201410422965.XA CN201410422965A CN104147194A CN 104147194 A CN104147194 A CN 104147194A CN 201410422965 A CN201410422965 A CN 201410422965A CN 104147194 A CN104147194 A CN 104147194A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- herba
- chronic sinusitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 69
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 206010009137 Chronic sinusitis Diseases 0.000 title claims abstract description 21
- 208000027157 chronic rhinosinusitis Diseases 0.000 title claims abstract description 21
- 239000002775 capsule Substances 0.000 claims abstract description 18
- 210000000582 semen Anatomy 0.000 claims abstract description 16
- 239000009670 cang er zi wan Substances 0.000 claims abstract description 15
- 239000008187 granular material Substances 0.000 claims abstract description 7
- 238000009835 boiling Methods 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 13
- 239000012535 impurity Substances 0.000 claims description 8
- 239000004375 Dextrin Substances 0.000 claims description 7
- 229920001353 Dextrin Polymers 0.000 claims description 7
- 235000019425 dextrin Nutrition 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 239000006200 vaporizer Substances 0.000 claims description 6
- 241000555712 Forsythia Species 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 19
- 238000002474 experimental method Methods 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 3
- 241001529821 Agastache Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 241000208689 Eucommia ulmoides Species 0.000 abstract 1
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 241001162994 Rugosus Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 206010019233 Headaches Diseases 0.000 description 7
- 231100000869 headache Toxicity 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 201000009890 sinusitis Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 210000003695 paranasal sinus Anatomy 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 206010028748 Nasal obstruction Diseases 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 210000001331 nose Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010002653 Anosmia Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010050515 Hyposmia Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010039101 Rhinorrhoea Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000019559 hyposmia Nutrition 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010016807 Fluid retention Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 208000010753 nasal discharge Diseases 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- -1 phenylacetyl Chemical group 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 206010067994 Mucosal atrophy Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000037306 mature skin Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000025938 nasal cavity disease Diseases 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 210000000492 nasalseptum Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000001944 turbinate Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
组别 | 例数 | 治愈 | 显效 | 有效 | 无效 | 总有效率 |
治疗组 | 56 | 14 | 28 | 11 | 3 | 94.6% |
对照组 | 56 | 10 | 20 | 11 | 15 | 73.2% |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410422965.XA CN104147194B (zh) | 2014-08-26 | 2014-08-26 | 一种治疗慢性鼻窦炎的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410422965.XA CN104147194B (zh) | 2014-08-26 | 2014-08-26 | 一种治疗慢性鼻窦炎的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104147194A true CN104147194A (zh) | 2014-11-19 |
CN104147194B CN104147194B (zh) | 2015-07-22 |
Family
ID=51872958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410422965.XA Expired - Fee Related CN104147194B (zh) | 2014-08-26 | 2014-08-26 | 一种治疗慢性鼻窦炎的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104147194B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105343614A (zh) * | 2015-11-23 | 2016-02-24 | 王建文 | 治疗慢性鼻窦炎的中药组合物 |
CN108042671A (zh) * | 2018-01-11 | 2018-05-18 | 广州市粤波医院(有限合伙) | 一种治疗痛风的中药组合药物及其制备方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105902683A (zh) * | 2016-04-26 | 2016-08-31 | 陈春波 | 一种治疗慢性鼻窦炎的中药 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103566028A (zh) * | 2013-10-24 | 2014-02-12 | 安徽工贸职业技术学院 | 一种治疗鼻窦炎的中药组合物 |
-
2014
- 2014-08-26 CN CN201410422965.XA patent/CN104147194B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103566028A (zh) * | 2013-10-24 | 2014-02-12 | 安徽工贸职业技术学院 | 一种治疗鼻窦炎的中药组合物 |
Non-Patent Citations (2)
Title |
---|
李凡成: "鼻部炎症辨证论治规律探讨", 《湖南中医学院学报》 * |
魏辉等: "中药治疗变应性鼻炎的研究进展", 《中医文献杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105343614A (zh) * | 2015-11-23 | 2016-02-24 | 王建文 | 治疗慢性鼻窦炎的中药组合物 |
CN108042671A (zh) * | 2018-01-11 | 2018-05-18 | 广州市粤波医院(有限合伙) | 一种治疗痛风的中药组合药物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104147194B (zh) | 2015-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103405596A (zh) | 一种治疗鼻窦炎的中药 | |
CN102188685B (zh) | 一种治疗腹泻型肠易激综合征的中药外敷散剂及其制备方法 | |
CN104147194B (zh) | 一种治疗慢性鼻窦炎的中药组合物 | |
CN104042713B (zh) | 一种治疗支气管哮喘病的中药组合物 | |
CN103908600B (zh) | 治疗类风湿性关节炎湿热痹阻证的外用药物及制备方法 | |
CN103585585B (zh) | 一种治疗胆总管结石的中药组合物及其制备方法 | |
CN105535495A (zh) | 一种培元固本治疗食管癌的中药组合物及制备方法 | |
CN102824576B (zh) | 治疗牛皮癣的中药组合物及其制备方法 | |
CN104706953A (zh) | 一种治疗慢性子宫颈炎的中药制剂 | |
CN104800675A (zh) | 用于治疗活动期溃疡性结肠炎的药物 | |
CN104857414A (zh) | 一种治疗慢性单纯性鼻炎的药物组合物 | |
CN104127827A (zh) | 一种治疗胆道结石症的中药制剂 | |
CN105288344A (zh) | 一种用于治疗肝胆结石的中药组合物及其应用 | |
CN104998106A (zh) | 一种治疗过敏性鼻炎的中药组合物 | |
CN105194588A (zh) | 一种治疗肝硬化的中药制剂 | |
CN105169111A (zh) | 一种用于治疗慢性荨麻疹的中药组合物及其应用 | |
CN104666922A (zh) | 一种治疗脾肾气虚型月经不调的中药组合物 | |
CN104958530A (zh) | 一种治疗小儿肺炎的中药组合物 | |
CN104189314A (zh) | 一种治疗痰浊阻遏证高血脂的药物组合物 | |
CN104474224A (zh) | 一种治疗痰湿内阻型病毒性心肌炎的中药 | |
CN103893509B (zh) | 一种治疗过敏性鼻炎的药物及制备方法 | |
CN104547190A (zh) | 一种治疗小儿黄疸的中药 | |
CN104116991A (zh) | 一种治疗放射病的中药制剂及制备方法 | |
CN104189610A (zh) | 一种治疗支气管炎的中药组合物 | |
CN104189154B (zh) | 一种治疗病毒性结膜炎的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: CHEN HONG Free format text: FORMER OWNER: WANG SHENJIAN Effective date: 20150228 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhao Yu Inventor before: Wang Shenjian |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG SHENJIAN TO: ZHAO YU Free format text: CORRECT: ADDRESS; FROM: 276017 LINYI, SHANDONG PROVINCE TO: 266000 QINGDAO, SHANDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150228 Address after: 266000 Qingdao City, Sifang District, Shandong flood water ditch village, No. 2, 106 Applicant after: Chen Hong Address before: 276017 Luozhuang Province, Linyi District, Zhao Zhao Road, No. 1072 Applicant before: Wang Shenjian |
|
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhao Yu Inventor after: Zhao Xiangwen Inventor before: Zhao Yu |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHAO YU TO: ZHAO YU ZHAO XIANGWEN |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Gao Zhiqiang Inventor after: Cheng Huiyun Inventor before: Zhao Yu Inventor before: Zhao Xiangwen |
|
COR | Change of bibliographic data | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161121 Address after: 261000 Weifang, Shandong, Kuiwei District College Street, No. 7 Patentee after: Gao Zhiqiang Patentee after: Yang Wenwen Address before: 266000 Qingdao City, Sifang District, Shandong flood water ditch village, No. 2, 106 Patentee before: Chen Hong |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150722 Termination date: 20170826 |
|
CF01 | Termination of patent right due to non-payment of annual fee |